The U.S. withdrawal from the World Health Organization (WHO) presents an opportunity for rethinking global health cooperation. The necessity for nations to collaborate is clear, driven by factors such as economic stability and the transnational nature of health threats. However, the focus should shift from creating new centralized emergency authorities, which can distort accountability and trust, to fostering a differentiated structure that allocates specific health functions appropriately. Historically, the WHO's role evolved to handle emergencies, particularly evident during the COVID-19 pandemic. This shift has generated permanent incentives around emergencies, complicating the declaration of normalcy and increasing challenges related to fragmented funding models that prioritize political agendas. Reform requires a division between routine health functions—like disease classification and lab standards—and emergency powers that directly impact national governance and rights. Event-triggered agreements could enhance cooperation by establishing clear health thresholds without permanent crisis management, thus preserving local governance. Future funding should link budgetary allocations to actual health outcomes rather than organizational ambitions, addressing distortions caused by earmarked contributions. The strengthening of national health systems is vital to reduce dependency and fortify resilience. Another opportunity lies in the 2027 election of a new WHO Director-General, which can catalyze a necessary debate on governance principles that include transparent budgeting, limited emergency powers, and an emphasis on accountable local implementation. Ultimately, the aim is to redesign global health cooperation before crises again dictate its structure, ensuring public trust and effective health governance.